LEADER 02015oam  2200457 a 450 
001 9910697868003321
005 20100216122429.0
035   $a(CKB)5470000002392301
035   $a(OCoLC)277050043
035   $a(EXLCZ)995470000002392301
100   $a20081205d2008      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrograms affecting safety and innovation in pediatric therapies$b[electronic resource] $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 22, 2007
210  1$aWashington :$cU.S. G.P.O.,$d2008.
215   $av, 153 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on Dec. 5, 2008).
300   $aPaper version available for sale by the Supt. of Docs., U.S. G.P.O.
300   $a"Serial no. 110-49."
320   $aIncludes bibliographical references.
517   $aPrograms affecting safety and innovation in pediatric therapies 
606   $aChildren$xDiseases$xTreatment$zUnited States$xSafety measures
606   $aChildren$xDiseases$xTreatment$xTechnological innovations$zUnited States$xSafety measures
606   $aPediatric pharmacology$zUnited States
606   $aPediatrics$vFormulae, receipts, prescriptions$xResearch$zUnited States
606   $aMedical instruments and apparatus$xSafety regulations$zUnited States
615  0$aChildren$xDiseases$xTreatment$xSafety measures.
615  0$aChildren$xDiseases$xTreatment$xTechnological innovations$xSafety measures.
615  0$aPediatric pharmacology
615  0$aPediatrics$xResearch
615  0$aMedical instruments and apparatus$xSafety regulations
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910697868003321
996   $aPrograms affecting safety and innovation in pediatric therapies$93524395
997   $aUNINA